CARECarter Bankshares, Inc.
Carter Bankshares, Inc. (CARE) is a regional bank focused on commercial and consumer lending in the Southeastern U.S. The next catalyst is Nov 3, 2026 — Q3 2026 Earnings Release, which will test the bank’s ability to deliver consistent earnings growth amid evolving macroeconomic conditions.
- Revenue grew 4.6% YoY to $20.32M, with a net margin of 633.0% TTM, suggesting strong asset quality and pricing power.
- Net income reached $128.60M, translating to a diluted EPS of $1.31, reflecting disciplined cost management and loan performance.
- Shareholders’ equity stands at $419.70M, with a capital structure that supports leverage without overexposure.
The Read
7% on macro catalysts including the June 17 period, with a notable 22.
The schedule
- Sun14Feb
This report will test the bank's ability to sustain its NIM and credit quality trends, with a focus on how the recent macroeconomic data and Fed policy impacts its balance sheet.
- Thu6May
This report will test the bank's ability to sustain its NIM and credit quality trends, with a focus on how the recent macroeconomic data and Fed policy impacts its balance sheet.
- Thu5Aug
This report will test the bank's ability to sustain its NIM and credit quality trends, with a focus on how the recent macroeconomic data and Fed policy impacts its balance sheet.
- Thu4Nov
Past
- Tue3Nov
Actual outcome: Mixed
CARE beat estimates with EPS of 5.80, signaling strong performance. The stock rose 0.7% as investors focused on stable NIM and credit quality, with positive macroeconomic signals reinforcing the bull case. The price remained above the bear floor, aligning with the bull target trajectory.
The earnings release will test whether the bank can maintain its NIM and credit quality trends, with a focus on how the recent macroeconomic data and Fed policy impacts its balance sheet.
- Thu6Aug
Actual outcome: Bear · $31.72 at outcome
CARE reported an EPS actual of 1.32, matching the estimate, indicating no earnings beat or miss. However, the stock fell 6.4% from the event date to the outcome date, likely due to mixed market sentiment around the strategic redeployment of $228M in cash and the lack of strong forward guidance. The announcement of the dividend reinvestment plan on August 11 may have been viewed as insufficient to offset concerns about the company's long-term growth prospects.
Q2 2026 earnings focusing on the strategic redeployment of $228M in cash generated from Q1's non-performing loan sale.
- Wed17Jun
Actual outcome: Bull · $30.96 at outcome
CARE shares exceeded the $30.00 bull target following the June FOMC meeting and rate path signal. In the absence of company-specific news, the stock's upward momentum was driven by the broader market's positive reaction to the Federal Reserve's interest rate decision and forward macroeconomic guidance.
Market reaction to the June 2026 FOMC interest rate decision and forward macroeconomic guidance.
- Wed20May
Actual outcome: Bull · $27.35 at outcome
Carter Bankshares executed a transformative sale of non-performing loans just prior to the annual meeting, realizing a $65 million gain and boosting tangible book value to $22.69 per share. This strategic move generated over $228 million in cash, positioning the bank to redeploy capital effectively and supporting a bullish outlook on its capital return policies, which ultimately drove the stock past the $27.50 bull target.
Annual meeting and update on capital return policies following a strong Q1 fundamental performance.
- Thu7May
Actual outcome: Bull · $29.88 at outcome
Carter Bankshares met Q1 2026 earnings expectations, reporting an EPS of $3.93 that exactly matched analyst estimates. The stock rallied 14.1% to easily surpass the $26.00 bull target, supported by strong underlying momentum and the strategic launch of new retail banking products aimed at deposit gathering. This steady fundamental performance and proactive approach to customer acquisition reassured investors, fueling a continued upward trajectory.
Q1 2026 results and management’s commentary on net interest margin, deposit costs, and credit quality will test Carter Bankshares’ recent rally near $24.41. With the stock overbought and trading well above a DCF estimate, the bar for a positive surprise is high; solid loan growth and stable charge-offs could support a move toward $26.00, while any margin compression or early credit deterioration could drive a reset toward $26.00.
- Wed18Mar
Actual outcome: Bull · $20.33 at outcome
Carter Bankshares rallied in response to the March FOMC meeting and the Federal Reserve's commentary on terminal rates. As a regional bank highly sensitive to interest rate expectations, the macroeconomic guidance provided a favorable backdrop for the financial sector, driving the stock steadily higher to comfortably exceed its $21.50 bull target.
- Thu5Mar
Actual outcome: Bear · $20.07 at outcome
CARE reported Q4 EPS of $0.39, exactly meeting analyst estimates. While the stock saw a minor 3.3% pullback in the week following the report, the in-line earnings and FY 2026 guidance provided fundamental stability that ultimately fueled a massive longer-term rally, sending shares well beyond the bull target.
Scouting Reports

Weekly Playbook: Monetizing the Outpatient Migration (CARE, CI, CON)
Nov 1, 2026
The structural shift from expensive inpatient hospital beds to high-efficiency ambulatory care is a massive reallocation of capital. As the aging population demands more frequent, lower-acuity interve
Read more →
Weekly Playbook: Pricing the Ambulatory Care Boom (SYK, CYH, FTRE)
Oct 25, 2026
The demographic shift toward an aging population is steadily forcing healthcare out of expensive inpatient wards and into ambulatory settings. The "Aging Population Drives Growth in Ambulatory Care" t
Read more →
Weekly Playbook: Pricing the Healthcare Gauntlet (ABEO, LFVN, KROS)
Oct 5, 2026
The healthcare and biotech sectors are defined by their bottlenecks. Whether a company is waiting on federal guidance or fighting to clear a clinical hurdle, the market brutally penalizes any friction
Read more →